Understanding immune responses in sarcoidosis
Official title: Immunologiska Mekanismer Vid Sarkoidos
Run by Region Stockholm · NCT06576505 · Data updated 2026-11-12
This study is trying to understand how the immune system works in people with sarcoidosis to see if it can help create better, personalized treatments for them.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Region Stockholm Government |
| Locations | 1 site (Stockholm, Stockholm County) |
| Status | Recruiting |
| Started | July 7, 2024 |
| Main results expected | December 31, 2029 |
| Study ends | December 31, 2034 |
| Registry record updated | March 6, 2026 |
| Trial ID | NCT06576505 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals suspected of having sarcoidosis who are Swedish-speaking and able to understand and approve the study protocol.
✕Probably not a fit
Patients who do not have a suspicion of sarcoidosis or are not Swedish-speaking may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the immunological mechanisms underlying sarcoidosis, an inflammatory disease that can affect various organs, particularly the lungs and lymph nodes. By analyzing peripheral blood, bronchoscopy samples, and gut microbiome data, the study seeks to identify genetic and immune factors that contribute to the variability in disease progression and treatment response among patients. The research will also include healthy controls to better understand the differences in immune responses. The findings could provide insights into personalized treatment approaches for sarcoidosis patients.
Why it matters
Potential benefit: If successful, this study could lead to more effective, personalized treatment strategies for patients with sarcoidosis.
How similar studies have gone: While the role of the gut microbiome in sarcoidosis is not well established, similar studies in other inflammatory diseases have shown promising results, indicating potential for success in this area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Suspicion of sarcoidosis * Swedish speaking * Able to understand and approve of study protocol * No contraindications for planned interventions * For inclusion of healthy controls they need to be healthy and the same criteria as listed above for patients. Exclusion Criteria: * No suspicion of sarcoidosis * Not Swedish-speaking * Not able to understand study protocol * Not approving of study protocol * Contraindications for planned interventions
Where it's running
-
Karolinska University Hospital
Stockholm, Stockholm County, Sweden Recruiting
Study contacts
- Principal investigator: Susanna M Kullberg, MD — Karolinska University Hospital
- Study coordinator: Susanna M Kullberg, MD
- Email: susanna.kullberg@regionstockholm.se
- Phone: 070-2715639
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Two prednisolone tapering plans for people with stable sarcoidosis
The team will try two different prednisolone tapering plans to see if people with stable sarcoidosis taking 5–10 mg/day can safely cut their dose by at least half.
-
Immune cells in lung disease and how they could guide immunotherapy
This project sees if immune cell profiling from blood can explain why people with lung cancer, sarcoidosis, or COPD respond differently to immunotherapy or develop chronic lung inflammation.
-
Imaging in Inflammatory Heart Diseases linked to autoimmune disorders
This study tests how well multimodality imaging (CMR, echocardiography, and PET) detects inflammation in people with suspected inflammatory heart or autoimmune rheumatic diseases.
-
Virtual groups to reduce sarcoidosis-related fatigue
This project tests whether an 8-week virtual Mindfulness-Based Stress Reduction (MBSR) program can help reduce fatigue and improve anxiety and depression in adults with sarcoidosis compared with a monthly virtual support group.
-
Counting and classifying inflammatory cells in uveitis with OCT
This project will try to use high-resolution OCT scans to count and categorize inflammatory cells and proteins in people with anterior uveitis and related eye inflammation.
-
Comparing yoga and physiotherapy for sarcoidosis treatment
This study is testing whether yoga or traditional physiotherapy helps people with sarcoidosis improve their lung function and feel better overall.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.